NCT05066334View on ClinicalTrials.gov

Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD

PHASE2RecruitingINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

March 22, 2021

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Intervertebral Disc DegenerationChronic Low-back Pain
Interventions
DRUG

Autologous BM-MSC

intradiscal injection of autologous bone marrow mesenchymal stromal cells

PROCEDURE

Sham

local anaesthesia, no disc injection, no placebo injection

Trial Locations (1)

00128

RECRUITING

Campus Bio-Medico University of Rome, Roma

All Listed Sponsors
collaborator

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

OTHER

collaborator

Center for Outcomes Research and Clinical Epidemiology, Italy

OTHER

lead

Fondazione Policlinico Universitario Campus Bio-Medico

OTHER